St. Jude Announces Key Approvals On Top Of Q1 Results
This article was originally published in The Gray Sheet
Executive SummarySt. Jude Medical last week announced two important regulatory approvals: a CE mark in Europe for its MRI-friendly pacemaker and an FDA PMA approval for its anticipated stented pericardial tissue heart valve device.
You may also be interested in...
Exact Sciences’ and Genomic Health announce favorable results for colon cancer tests. Boston Scientific launches trial of MRI-safe pacemaker. More research news.